Editas Medicine, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-83.1M | $143.2M |
| FY2016 | — | $134.6M | $185.3M |
| FY2017 | — | $208.1M | $146.6M |
| FY2018 | — | $236.2M | $134.8M |
| FY2019 | — | $262.4M | $238.2M |
| FY2020 | — | $393.6M | $139.7M |
| FY2021 | — | $553.6M | $203.5M |
| FY2022 | — | $360.7M | $141.5M |
| FY2023 | $0 | $349.1M | $123.7M |
| FY2024 | $52.4M | $134.3M | $131.5M |
| FY2025 | $53.6M | $27.3M | $146.6M |